COMBINED sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex, Dronabinol and Sativex – are set to reach
LONDON Stock Exchange debutant Oxford Cannabinoid Technologies is aiming to emulate the success of GW Pharmaceuticals. Its founders Gavin Sathianathan
THE last few weeks have witnessed a wild ride for global cannabis stocks reminiscent of some of the earlier bubbles
We won’t spam you
